University of Mississippi, Oxford
13
1
1
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
7.7%
1 terminated/withdrawn out of 13 trials
90.9%
+4.4% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Vascular Adaptations to Single-Sprint Training
Role: lead
Exposure Therapy Consortium (ETC) for Anxiety Sensitivity
Role: collaborator
Time-restricted Eating Acceptability, Efficacy and Safety in Obesity
Role: lead
Primaquine Enantiomers in G6PD Deficient Human Volunteers
Role: lead
CBD Cannabis Extract: Pharmacokinetic Studies
Role: lead
Effects of Early Time Restricted Eating on Muscle Performance in Resistance Trained Individuals
Role: lead
Online Education Intervention to Reduce Ageism Among Undergraduate Students
Role: lead
Metabolism and Pharmacokinetics of Primaquine Enantiomers in Human Volunteers Receiving a Seven Day Dose Regimen
Role: lead
Metabolism and Pharmacokinetics of Primaquine Enantiomers in Human Volunteers, Study 1
Role: lead
Transtheoretical Model of Behavior Change and Anxiety
Role: lead
Method of Fish Oil Administration on Patient Compliance
Role: lead
Effects of Narrative Writing Duration and Post-writing Processing Instructions on PTSD
Role: lead
The Effects of Tactile Speech Feedback on Stuttering Frequency
Role: lead
All 13 trials loaded